ENPH Stock Cash Flow Statements

Enphase Energy Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Enphase Energy Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31

cash flows from operating activities:
net income	37,052,000	29,730,000	62,160,000	45,762,000	10,833,000	-16,097,000	20,919,000	113,953,000	157,191,000	146,873,000	153,753,000	114,812,000	76,976,000	51,821,000	52,591,000	21,809,000	39,351,000	31,698,000	72,991,000	39,362,000	-47,294,000	68,936,000	116,666,000	31,099,000	10,618,000	2,765,000	709,000	-3,470,000	-3,738,000	-5,128,000	-2,940,000	-6,854,000	-12,093,000	-23,305,000	-13,188,000	-18,756,000	-16,723,000	-18,795,000	-15,783,000	624,000	-603,000	-6,320,000	402,000	813,000	-3,031,000	-6,236,000	-2,810,000	-6,301,000	-6,396,000	-10,406,000	-7,742,000	-8,907,000	-11,385,000	-10,184,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	20,085,000	19,915,000	20,665,000	20,103,000	20,484,000	20,137,000	20,841,000	19,448,000	17,828,000	16,591,000	16,009,000	11,961,000	15,247,000	15,558,000	10,972,000	8,313,000	7,596,000	5,558,000	5,353,000	4,765,000	4,141,000	3,844,000	2,568,000	3,857,000	4,122,000	3,572,000	2,717,000	2,481,000	2,193,000	2,276,000	2,241,000	2,180,000	2,255,000	2,328,000	2,599,000	2,651,000	2,708,000	2,680,000	2,835,000	2,650,000	2,522,000	2,532,000	2,255,000	2,102,000	1,992,000	1,910,000	1,859,000	1,753,000	1,709,000	1,660,000	1,630,000	1,487,000	1,366,000	1,085,000
net amortization of premium on marketable securities	-1,234,000	3,512,000
benefit from credit losses
asset impairment	1,538,000	27,000	4,702,000	17,568,000	6,241,000	332,000	9,700,000				0	0
non-cash interest expense	828,000	1,679,000	2,188,000	2,173,000	2,157,000	2,132,000	2,126,000	2,114,000	2,106,000	2,034,000	2,077,000	2,065,000	2,046,000	1,979,000	12,494,000	12,430,000	12,307,000	7,156,000	5,309,000	5,422,000	5,372,000	2,722,000	1,908,000	1,907,000													28,000	28,000	43,000	40,000	41,000	39,000	227,000	65,000	89,000	102,000	107,000	107,000	107,000	108,000	808,000	66,000
net income from change in fair value of debt securities
stock-based compensation	53,896,000	55,633,000	51,830,000	45,940,000	52,757,000	60,833,000	55,222,000	43,814,000	54,166,000	59,655,000	63,645,000	52,296,000	53,064,000	47,797,000	37,176,000	46,954,000	15,312,000	14,844,000	8,289,000	14,399,000	12,300,000	7,515,000	6,176,000	5,776,000	4,934,000	3,290,000	1,521,000	4,051,000	4,289,000	1,571,000	1,450,000	1,727,000	1,621,000	1,929,000	2,087,000	2,532,000	2,708,000	2,999,000	3,117,000	3,283,000	3,308,000	2,988,000	2,703,000	2,530,000	2,494,000	2,013,000	1,894,000	2,045,000	1,475,000	1,435,000	1,607,000	1,451,000	1,002,000	706,000
deferred income taxes	403,000	8,560,000	-30,675,000	-5,276,000	-14,076,000	-8,292,000	-5,053,000	-11,499,000	-10,615,000	-16,181,000	-12,099,000	115,000	12,452,000	3,165,000	-2,451,000	1,337,000	5,240,000	-35,367,000	-2,610,000	5,060,000	-7,067,000	-12,500,000
changes in operating assets and liabilities:
accounts receivable	8,681,000	1,760,000	2,684,000	49,414,000	82,183,000	77,359,000	105,771,000	-34,752,000	-3,968,000	-79,529,000	-88,876,000	-46,226,000	51,770,000	-24,224,000	-58,091,000	5,462,000	-44,812,000	-53,719,000	-57,854,000	-32,633,000	6,529,000	49,637,000	-12,606,000	-37,035,000	-15,838,000	-3,266,000	-24,186,000	4,774,000	-3,228,000	9,125,000	3,958,000	-12,671,000	-8,065,000	11,975,000	-1,440,000	-12,372,000	-2,711,000	-1,494,000	28,065,000	-8,252,000	-21,544,000	-751,000	4,151,000	-2,733,000	-18,772,000	3,608,000	2,647,000	-3,277,000	-7,224,000	2,835,000	3,983,000	-22,833,000	3,486,000	4,324,000
inventory	-28,991,000	20,979,000	-6,167,000	17,231,000	31,825,000	5,702,000	-39,481,000	-8,003,000	-15,548,000	-855,000	-3,222,000	-16,185,000	-33,830,000	-22,036,000	-5,618,000	-27,648,000	-2,880,000	6,888,000	-4,229,000	-6,349,000	3,430,000	-2,560,000	-1,825,000	-10,137,000	-7,123,000	3,296,000	1,620,000	-416,000	1,071,000	7,457,000	-683,000	-4,477,000	12,969,000	-1,848,000	7,141,000	194,000	6,281,000	-4,776,000	-4,083,000	-2,663,000	692,000	-13,156,000	-6,102,000	236,000	-1,611,000	2,467,000	7,812,000	-6,486,000	4,403,000	-2,466,000	-3,193,000	14,316,000	-5,305,000	-14,433,000
prepaid expenses and other assets	-64,261,000	-75,553,000	-16,487,000	-64,149,000	-42,810,000	-10,897,000	-2,401,000	-15,383,000	-20,536,000	-21,457,000	-47,597,000	526,000	-18,310,000	-3,042,000	-8,123,000	-3,568,000	-10,154,000	-5,040,000	-4,185,000	-917,000	-4,525,000	-5,009,000	-5,659,000	934,000	-7,155,000	-2,413,000	865,000	-2,444,000	-512,000	-1,039,000	3,883,000	228,000	-2,224,000	-3,114,000	-902,000	-160,000	-1,635,000	-2,062,000	-273,000	-931,000	-2,008,000	-2,069,000	-680,000	405,000	-1,295,000	-977,000	-481,000	-443,000	-171,000	-355,000	-263,000	869,000	-404,000	-913,000
accounts payable, accrued and other liabilities	37,212,000	54,232,000	-27,396,000	32,088,000	-23,944,000	-66,284,000	-139,277,000	9,903,000	24,685,000	82,540,000	91,128,000	32,060,000	12,033,000	-1,805,000	45,396,000	24,897,000	10,514,000	36,376,000	44,895,000	26,189,000	-13,323,000	-22,066,000	3,544,000	1,851,000	11,954,000	4,851,000	18,410,000	8,489,000	7,850,000	-11,667,000	-8,129,000	17,158,000	3,351,000	-17,458,000	-5,970,000	-471,000	13,109,000	2,229,000	-7,624,000	-1,708,000	4,407,000	2,305,000	2,687,000					8,681,000	3,933,000	-759,000	3,231,000	-3,176,000	5,497,000	11,222,000
warranty obligations	2,639,000	10,558,000	8,657,000	7,053,000	15,000	-11,923,000	221,000	8,151,000	34,681,000	14,588,000	25,566,000	9,329,000	12,972,000	9,906,000	5,417,000	7,574,000	5,385,000	8,640,000	2,134,000	5,872,000	406,000	403,000	2,474,000	1,631,000	1,951,000	-252,000	-890,000	542,000	1,017,000	809,000	-536,000	-1,261,000	-381,000	580,000	1,065,000	283,000	407,000	-888,000	-2,259,000	-957,000	-400,000	223,000	1,633,000	-662,000	2,241,000	296,000
deferred revenues	-50,813,000	-82,357,000	104,112,000	1,690,000	-1,401,000	-5,554,000	12,611,000	13,369,000	40,715,000	51,085,000	58,331,000	25,764,000	16,033,000	22,061,000	13,859,000	16,399,000	28,469,000	19,440,000	14,011,000	6,262,000	5,689,000	-36,460,000	61,467,000	4,877,000	4,326,000	1,578,000	4,157,000	-3,489,000	-5,611,000	-1,180,000	292,000	1,416,000	2,225,000	1,395,000	2,535,000	2,182,000	2,289,000	4,268,000	2,495,000	2,127,000	2,633,000	2,416,000	1,602,000	2,177,000	1,616,000	-93,000	752,000	2,744,000	1,115,000	976,000	1,550,000	1,238,000	-15,210,000	-6,192,000
net cash from operating activities	26,629,000	48,414,000	167,292,000	170,138,000	127,062,000	49,201,000	35,450,000	145,855,000	269,243,000	246,232,000	253,714,000	188,010,000	200,650,000	102,443,000	97,173,000	113,354,000	65,660,000	75,841,000	84,180,000	67,501,000	25,431,000	39,222,000	102,271,000	4,961,000	14,772,000	17,063,000	1,875,000	6,816,000	4,080,000	3,361,000	-1,914,000	-2,203,000	186,000	-24,511,000	-4,365,000	-20,597,000	7,258,000	-15,249,000	8,149,000	-6,038,000	-11,773,000	-11,498,000	8,880,000	11,208,000	-147,000	4,281,000	7,579,000	-489,000	-990,000	-6,972,000	7,629,000	-20,429,000	-17,774,000	-14,071,000
capex	-7,906,000	-9,546,000	-8,064,000	-7,819,000	-12,526,000	527,000	-20,075,000	-15,975,000	-45,506,000	-12,662,000	-16,429,000	-6,365,000	-10,260,000	-7,275,000	-13,208,000	-12,682,000	-16,428,000	-9,940,000	-8,851,000	-3,903,000	-4,451,000	-3,353,000	-7,420,000	-4,192,000	-2,518,000	-658,000	-1,767,000	-909,000	-432,000	-1,043,000	-512,000	-94,000	-49,000	-3,466,000	-2,560,000	-2,097,000	-4,162,000	-3,348,000	-2,843,000	-4,449,000	-2,307,000	-2,342,000	-2,864,000	-4,887,000	-1,983,000	-1,675,000	-836,000	-1,422,000	-1,970,000	-1,192,000	-1,576,000	-4,321,000	-3,424,000	-2,897,000
free cash flows	18,723,000	38,868,000	159,228,000	162,319,000	114,536,000	49,728,000	15,375,000	129,880,000	223,737,000	233,570,000	237,285,000	181,645,000	190,390,000	95,168,000	83,965,000	100,672,000	49,232,000	65,901,000	75,329,000	63,598,000	20,980,000	35,869,000	94,851,000	769,000	12,254,000	16,405,000	108,000	5,907,000	3,648,000	2,318,000	-2,426,000	-2,297,000	137,000	-27,977,000	-6,925,000	-22,694,000	3,096,000	-18,597,000	5,306,000	-10,487,000	-14,080,000	-13,840,000	6,016,000	6,321,000	-2,130,000	2,606,000	6,743,000	-1,911,000	-2,960,000	-8,164,000	6,053,000	-24,750,000	-21,198,000	-16,968,000
cash flows from investing activities:
purchases of property and equipment	-8,259,000	-14,608,000	-8,064,000	-8,533,000	-9,636,000	-7,371,000	-20,075,000	-23,848,000	-44,002,000	-22,476,000	-16,429,000	-8,948,000	-8,691,000	-12,375,000	-13,208,000	-12,682,000	-16,428,000	-9,940,000	-8,851,000	-3,903,000	-4,451,000	-3,353,000	-7,420,000	-4,192,000	-2,518,000	-658,000	-1,767,000	-909,000	-432,000	-1,043,000	-512,000	-94,000	-49,000	-3,466,000	-2,560,000	-2,097,000	-4,162,000	-3,348,000	-2,843,000	-3,422,000	-2,649,000	-3,611,000	-3,413,000	-5,503,000	-2,161,000	-2,172,000	-1,371,000	-1,419,000	-1,785,000	-1,682,000	-1,936,000	-3,041,000	-3,408,000	-4,605,000
investment in tax equity fund	-1,440,000	-6,904,000
purchases of marketable securities	-284,306,000	-200,826,000	-93,138,000	-319,190,000	-300,053,000	-472,268,000	-337,757,000	-470,766,000	-577,521,000	-695,387,000	-335,193,000	-512,176,000			-389,466,000
maturities and sale of marketable securities	242,820,000	335,398,000	351,843,000	215,241,000	282,063,000	497,373,000	433,869,000	494,804,000	557,471,000	354,333,000
net cash from investing activities	-51,185,000	113,060,000	250,641,000	-112,482,000	-27,626,000	17,734,000	76,037,000	-14,810,000	-64,052,000	-363,530,000	-118,131,000	-338,001,000	44,491,000	39,735,000	-556,518,000	-536,422,000	-36,428,000	-90,179,000	-13,861,000	-3,903,000	-4,451,000	-3,353,000	-7,420,000	-4,192,000	-2,518,000	-658,000	-7,767,000	-9,909,000	-432,000	-1,043,000	-512,000	-94,000	-49,000	-3,466,000	-1,510,000	-2,097,000	-4,840,000	-3,348,000	-2,780,000	-3,422,000	-2,649,000	-3,611,000	-6,698,000	-5,503,000	-2,161,000	-2,172,000	-1,371,000	-1,419,000	-1,785,000	-1,682,000	-1,936,000	-3,041,000	-3,408,000	-4,605,000
cash flows from financing activities:
settlement of notes due 2025	0	-102,168,000
proceeds from issuance of common stock under employee equity plans	5,302,000	67,000	4,719,000	14,000	6,769,000	1,186,000
payment of withholding taxes related to net share settlement of equity awards	-2,864,000	-12,110,000	-5,012,000	-6,286,000	-7,473,000	-60,042,000	-27,546,000	-8,465,000	-12,790,000	-71,845,000	-8,100,000	-4,589,000	-5,463,000	-9,344,000	-8,825,000	-3,313,000	-7,813,000	-9,185,000	-16,288,000	-8,390,000	-9,385,000	-34,267,000	-3,760,000
repurchase of common stock	-29,993,000	-99,964,000	-199,666,000	-49,794,000	-99,908,000	-41,996,000	-99,998,000	-110,000,000							-300,000,000	0
net cash from financing activities	-27,555,000	-214,175,000	-202,732,000	-56,071,000	-100,612,000	-100,854,000	-114,989,000	-117,746,000	-212,234,000	-71,805,000	-3,010,000	-3,896,000	-1,280,000	-8,940,000	-306,232,000	-3,271,000	-205,757,000	824,671,000	-53,635,000	-9,164,000	-7,594,000	262,071,000	-1,966,000	-3,140,000	115,378,000	-44,422,000	-3,996,000	60,866,000	2,014,000	21,730,000	2,558,000	4,000	149,000	40,586,000	-265,000	38,540,000	-6,946,000	3,046,000	698,000	122,000	19,067,000	677,000	-4,453,000	1,587,000	-64,000	-412,000	125,000	-481,000	326,000	-28,000	-2,170,000	-1,680,000	56,259,000	-973,000
effect of exchange rate changes on cash, cash equivalents and restricted cash	7,557,000	3,675,000
net decrease in cash, cash equivalents and restricted cash	-44,554,000	-49,026,000
cash, cash equivalents and restricted cash — beginning of period
cash, cash equivalents and restricted cash — end of period
supplemental cash flow disclosure:
supplemental disclosures of non-cash investing activities:
purchases of property and equipment through tenant improvement allowance	0	855,000										0	0	748,000
purchases of property and equipment included in accounts payable	353,000	4,207,000		714,000	-2,890,000	7,898,000		7,873,000	-1,504,000	9,814,000		2,583,000	-1,569,000	4,352,000																										-1,027,000	342,000	1,269,000	549,000	616,000	178,000	497,000	535,000	-3,000	-185,000	490,000	360,000	-1,280,000	-16,000	1,708,000
benefit for credit losses		62,000
net gain from change in fair value of debt securities		-323,000	-3,697,000	741,000	1,931,000	-942,000	-2,670,000
cash, cash equivalents and restricted cash—beginning of period		464,116,000														0	0	679,379,000	0	0	0	296,109,000
cash, cash equivalents and restricted cash—end of period		415,090,000																				593,844,000
net accretion of discount on marketable securities			-7,490,000
investments in private companies							0				-15,000,000				0	-13,000,000
business acquisitions, net of cash acquired											-34,482,000	0	-3,055,000	-24,625,000	-180,413,000	0	0	-55,239,000
partial settlement of convertible notes			0	-5,000	0	-2,000
payment of excise tax on net stock repurchases
net increase in cash, cash equivalents and restricted cash																-426,715,000	-176,749,000	809,631,000
cash and cash equivalents—beginning of period			0	0	0	288,748,000	0	0	0	473,244,000	0	0	0	119,316,000										0	0	106,237,000	0	0	0	29,144,000		0	0	17,764,000		0	0	28,452,000		0	0	42,032,000		0	0	38,190,000		0	0	45,294,000		0	0	51,524,000
benefit from doubtful accounts				2,704,000			-129,000	653,000	449,000	180,000	67,000	-79,000	-16,000	147,000	27,000	179,000	257,000	14,000	171,000	69,000	81,000	104,000	-191,000	201,000			43,000	-85,000	153,000	600,000	-435,000	204,000	565,000	142,000	-97,000	1,863,000	794,000	537,000	1,158,000	245,000			0	0	685,000	26,000	13,000	637,000			1,008,000
effect of exchange rate changes on cash and cash equivalents				2,638,000	-374,000	-1,177,000	2,175,000	-1,900,000	-326,000	1,904,000	3,088,000	-4,003,000	-238,000	-704,000		-376,000	-224,000	-702,000	903,000	104,000	24,000	-205,000
net decrease in cash and cash equivalents				4,223,000	-1,550,000	-35,096,000																														15,869,000	-4,773,000	-15,436,000												-8,860,000				-19,621,000
cash and cash equivalents—end of period				4,223,000	-1,550,000	253,652,000	-1,327,000	11,399,000	-7,369,000	286,045,000	135,661,000	-157,890,000	243,623,000	251,850,000						54,538,000				-2,913,000	127,872,000	78,087,000	-9,927,000	57,693,000	5,216,000	53,255,000		-2,075,000	998,000	29,955,000		15,869,000	-4,773,000	13,016,000		-9,396,000	4,760,000	27,127,000		6,916,000	-2,314,000	39,935,000		-2,198,000	-2,458,000	36,434,000		-25,252,000	35,066,000	31,903,000
net amortization (accretion) of premium (discount) on marketable securities					-1,030,000	2,825,000	-2,950,000	5,094,000
benefit for doubtful accounts						-130,000
loss on partial settlement of convertibles notes															115,000	0	13,000	56,369,000
deemed repayment of convertible notes attributable to accreted debt discount															-133,000	0	-6,000	-15,579,000
gain on settlement of debt securities
purchase of intangible asset															0
redemption of investment in private companies
issuance of convertible notes, net of issuance costs															0	0	-949,000	1,189,388,000	0	0	-591,000	313,011,000
purchase of convertible note hedges															0	0	0	-286,235,000	0	0	0	-89,056,000	0	0
sale of warrants															0	0	0	220,800,000	0	0	0	71,552,000	-1,000	0
principal payments and financing fees on debt															-272,000	0	-344,000	-1,078,000	-306,000	-636,000	-485,000	-1,148,000	-197,000	-536,000	-391,000	-44,731,000
partial repurchase of convertible notes															-935,000	0	-79,000	-289,233,000
proceeds from exercise of equity awards and employee stock purchase plan							12,555,000	719,000	556,000	40,000	5,090,000	693,000	4,183,000	404,000	3,800,000	42,000	3,428,000	214,000	3,687,000	-138,000	2,867,000	1,979,000
net increase in cash and cash equivalents							-1,327,000	11,399,000	-7,369,000	-187,199,000	135,661,000	-157,890,000	243,623,000	132,534,000						54,538,000				-2,913,000	127,872,000	-28,150,000	-9,927,000	57,693,000	5,216,000	24,111,000	266,000	-2,075,000	998,000	12,191,000					5,961,000			-14,905,000	-2,505,000			1,745,000	6,412,000	-2,198,000
supplemental disclosures of non-cash investing and financing activities:
net (gain) income from change in fair value of debt securities
amortization of marketable securities premiums, net of accretion of purchase										-7,548,000
change in fair value of debt securities										-1,744,000	-345,000	-519,000	-987,000	1,116,000	111,000	-784,000
amortization of marketable securities premiums, net of accretion of purchase discounts											-4,723,000
change in fair value of derivatives																			0	0	59,692,000	-15,344,000
maturities of marketable securities											282,973,000	184,123,000	116,298,000	76,735,000	0
contingent consideration in connection with the acquisition																-96,000
convertible senior note issuance costs included in accounts payable and accrued expense																						591,000
financing fees on extinguishment of debt																							0	0	0	2,152,000
fees paid for repurchase and exchange of convertible notes due 2023																							0	0
purchases of fixed assets included in accounts payable																2,692,000				496,000	1,051,000	585,000		-268,000	736,000	458,000	770,000
change in fair value of debt security																		-1,437,000
investment in a private company																		-25,000,000
cash. cash equivalents and restricted cash—end of period																		1,489,010,000
loss on partial repurchase of convertibles notes due 2024
deemed repayment of convertible notes due 2024 attributable to accreted debt discount
intangible assets																											-4,000,000
purchase of investment in private company
acquisition																											-6,000,000
proceeds from issuance of common stock, net of issuance costs																											-5,000	-152,000	0	19,923,000		0	-97,000	26,522,000
proceeds from debt, net of issuance costs
partial repurchase of convertible notes due 2024
accrued interest payable unpaid upon exchange of convertible notes due 2023																								0
net increase in cash, cash equivalents, and restricted cash																						297,735,000
reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets
cash and cash equivalents																						549,144,000
restricted cash																						44,700,000
total cash, cash equivalents, and restricted cash																						593,844,000
issuance of convertible notes due 2024, net of issuance costs																							-68,000	-559,000
payments under revolving credit facility																															0	0	0	-10,100,000	-2,350,000	0	-7,550,000	-7,000,000
proceeds from exercise of equity awards
effect of exchange rate changes on cash																								-542,000	240,000	-133,000	-39,000	-80,000	-446,000	63,000	134,000	218,000	712,000	-418,000	-208,000	23,000	-245,000	115,000	-106,000	-58,000	115,000	-473,000	-234,000	-376,000	58,000	48,000	79,000	191,000	-9,000	-178,000	54,000	-102,000	-11,000	28,000
acquisition funded by issuance of common stock																											0
acquisition funded by accrued liabilities
proceeds from issuance of common stock under employee stock plans																									223,000	309,000	649,000	781,000	1,101,000	269,000	356,000	4,000	168,000	2,000	292,000	43,000	708,000	101,000	1,148,000	122,000	2,067,000	677,000	1,408,000	2,257,000	1,247,000	454,000	757,000	138,000
amortization of debt issuance costs																										1,490,000	821,000	747,000	596,000	537,000	336,000	274,000	118,000	945,000	44,000
operating lease, right of use asset																										8,392,000
gain on business divestiture
deferred income tax expense
purchases of intangible assets																																			0	0
business divestitures
proceeds from borrowings under revolving credit facility																																			0	0	0	10,000,000
principal payments on debt
cash paid for interest																																															322,000	354,000	327,000	388,000	431,000	346,000	390,000	514,000
cash paid for income taxes
offering and loan costs included in accrued liabilities
asset impairment charges
proceeds from debt																												62,772,000	3,271,000	2,309,000
principal payments on term debt																												-2,535,000	-2,358,000	-771,000
warrants issued in connection with debt																																0	0	1,447,000
asset impairment and restructuring																															43,000	-127,000	-155,000	1,920,000
purchases of fixed and intangible assets included in accounts payable																													-5,000	117,000	-320,000	560,000	-998,000	1,309,000	183,000	-421,000	-753,000	1,691,000
deferred debt and offering costs included in accounts payable																																		231,000
operating activities:
revaluation of contingent consideration liability																																							-227,000	-700,000	-1,004,000	104,000
deferred income tax (benefit) expense
changes in operating assets and liabilities
investing activities:
change in restricted cash
financing activities:
proceeds from common stock offerings, net of issuance costs
holdback payment related to prior acquisition
cash and cash equivalents — beginning of year
cash and cash equivalents — end of year
noncash financing and investing activities:
proceeds from term loan																																0	78,000	24,162,000
payments of deferred financing costs																																						-55,000
contingent consideration payment related to prior acquisition																																				0
proceeds from public offering of common stock, net of offering costs
proceeds from term loan, net of issuance costs
repayments of term loans																																											-5,861,000	-670,000	-1,311,000	-866,000	-632,000	-619,000	-605,000	-591,000	-8,581,000	-1,446,000	-789,000	-3,287,000
proceeds from public offering of common stock, net of underwriting fees
payments for debt issuance costs and offering costs
deferred public offering costs included in accounts payable
net income on disposal of assets																																					3,000	25,000	43,000	204,000	84,000	191,000	2,000	219,000	22,000	6,000	0	51,000			10,000	0
payments for deferred financing costs
acquisition of a business
principal payments under capital leases																																															0	0	0	-40,000	0	-33,000	-32,000	-31,000
cash and cash equivalents — beginning of period
cash and cash equivalents — end of period
supplemental disclosures of cash flow information:
acquisition-related contingent consideration liability
borrowings under revolving credit facility																																								17,000,000
payments toward revolving credit facility
change in fair value of convertible preferred stock warrants																																																			0	0	103,000	-623,000
purchase of patents
proceeds from borrowings under term loans
payments of financing costs
proceeds from issuance of common stock in ipo, net of underwriting discounts and commissions																																																			0	0
payment of offering costs																																																			-166,000	-204,000
non-cash financing and investing activities:
conversion of convertible notes into common stock upon ipo																																																			0	0
reclassification of convertible preferred stock warrant liability to additional paid-in capital upon ipo																																																			0	0
accounts payable, accrued compensation and other accrued liabilities																																													15,423,000	1,159,000
accounts payable, accrued liabilities and warranty obligations
proceeds from issuance of convertible notes
costs related to issuance of convertible notes
proceeds from private placement of common stock
assets acquired under capital lease
offering costs not yet paid
prepayment to supplier
proceeds from term loans and debt																																																				0
proceeds from the exercise of stock options																																																		603,000		3,000	20,000	24,000
proceeds from issuance of convertible preferred stock
costs related to issuance of convertible preferred stock
term loan and debt issuance costs
other financing costs not yet paid
noncash interest expense																																																						937,000
proceeds from term loans																																																						2,600,000
term loan issuance costs
deferred offering costs																																																						-279,000
deferred offering costs not yet paid																																																						1,753,000

We provide you with 20 years of cash flow statements for Enphase Energy stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Enphase Energy stock. Explore the full financial landscape of Enphase Energy stock with our expertly curated income statements.

The information provided in this report about Enphase Energy stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.